Read More Apparatus "New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial Nov 10, 2024
Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Medical Significant Improvement In Survival For Pancreatic Cancer Patients! A first-Line NALIRIFOX Regimen To Look Forward To! Nov 08, 2024
